Feature | Normal | Infective | IBD | UC | CD | UC (p) | References |
---|---|---|---|---|---|---|---|
Architecture | |||||||
Normal crypt architecture | 100 | 85 | 8 | 6–10 | 34 | 18 28 34 63 | |
Parallel crypts | 87 | 53 | 4 | ||||
Irregular/villous surface | 0 | 0–7 | 11–27 | 30–50 | 12 | 32 | 4 11 18 25 26 28 33 34 |
Crypt architectural distortion | 0–30 | 28–100 | 57–89 | 27–32 | 66 | 4 18 25 26 28 32 33 63 | |
Crypt branching | 0–5 | 10 | 79 | 47–63 | 39 | 28 | 11 18 28 34 |
Vertical crypt branching | 0 | 24 | 4 | ||||
Horizontal crypt branching | 55 | 82 | 4 | ||||
Crypt dilatation | 8–14 | 53 | 80 | 57 | 42 | 4 11 34 | |
Crypt atrophy | 0–15 | 10–33 | 29–66 | 12–23 | 38 | 4 11 18 25 28 33 | |
Epithelium | |||||||
Mucin depletion | 17 | 70 | 92 | 67–69 | 29–57 | 11 18 63 | |
Paneth cell metaplasia | 6 | 0 | 4–15 | 16–19 | 4 | 9 | 4 11 26 28 |
Chronic inflammation | |||||||
Basal plasmacytosis | 0 | 0–6 | 69–100 | 76 | 58 | 4 18 28 32 34 | |
Basal lymphoid aggregates | 0–7 | 18–35 | 21–60 | 8 | 64 | 18 25 26 28 33 | |
Mixed LP inflammation | 0–31 | 38–94 | 27 | 27 | 18 25 | ||
Superficial hypercellularity | 28 | 10 | 4 | ||||
Granuloma | 0 | 0–2 | 6–27 | 21–62 | 4 11 18 25 26 33 34 63 | ||
Giant cells | 0 | 2 | 25 | 1 | 11 | 11 18 | |
Basal giant cells | 0–2 | 1–16 | 25 26 33 | ||||
Superficial giant cells | 16 | 3 | 3 | 0 | 25 | ||
Neutrophils | |||||||
Lamina proprial neutrophils | 6 | 47–86 | 0–73 | 61–63 | 55–61 | 4 11 18 25 63 | |
Crypt abscesses | 0 | 47–54 | 75–90 | 41–66 | 19 | 53 | 18 25 28 34 63 |
Cryptitis | 0 | 8–64 | 52 | 81 | 28 34 63 | ||
Ulceration/lumenal pus | 0 | 0 | 31–40 | 24–25 | 11 34 63 | ||
Surface erosions | 9–76 | 24–93 | 37 | 7 | 25 32 33 |
CD: Crohn's disease; IBD, inflammatory bowel disease; LP, lamina propria; UC, ulcerative colitis; UC (p), paediatric ulcerative colitis.